A Phase I Trial of Bortezomib and Sunitinib

This study has been completed.
Sponsor:
Collaborators:
Millennium Pharmaceuticals, Inc.
Pfizer
Information provided by (Responsible Party):
R. Donald Harvey, PharmD, Emory University
ClinicalTrials.gov Identifier:
NCT00720148
First received: July 18, 2008
Last updated: August 25, 2014
Last verified: August 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2010
  Primary Completion Date: July 2010 (Final data collection date for primary outcome measure)